AIT Bioscience competitors

AIT Bioscience Competitors include Cmed, Hanger, Advanced Oncotherapy and Affymetrix.
Add company...
AIT Bioscience
AIT Bioscience
AIT Bioscience offers bioanalytical contract research services for preclinical and clinical trials.
Cmed
Cmed
Cmed is a full service, global CRO specialized in the design and delivery of innovative and traditional early phase patient clinical trials.
Hanger
Hanger
Empowering human potential with innovative technologies, efficient and effective clinical solutions, and outstanding customer service.
Advanced Oncotherapy
Advanced Oncotherapy
Advanced Oncotherapy is a medical technology company providing advanced radiotherapy systems for the treatment of common and rare cancers.
Affymetrix
Affymetrix
Affymetrix develops and provides technologies that enable multiplex and parallel analysis of biological systems at the cell protein, and gene level.
Founding Date
Founding Date
2009
Founding Date
1999
Founding Date
1861
Founding Date
1994
Founding Date
1994
Type
Type
Private
Type
Private
Type
Public
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Indianapolis, US HQ
Locations
West Sussex, GB HQ
Sânnicolau Mare, RO
San Bruno, US
Durham, US
Cambridge, US
Locations
Austin, US HQ
Locations
London, GB HQ
Rolle, CH
Syracuse, US
Locations
Santa Clara, US HQ
Vienna, AT
Shanghai, CN
Singapore, SG
High Wycombe, GB
San Diego, US
see more
Employees
Employees
582% increase
Employees
2904% increase
Employees
4,600
Employees
51
Employees
N/A
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
705.5 m
Valuation ($)
28.9 m
Valuation ($)
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
2.9 k
Twitter followers
821
Twitter followers
2

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
£2.4m (FY, 2017)
Revenue (est.)
$1b (FY, 2018)
Revenue (est.)
N/A
Revenue (est.)
$359.8m (FY, 2015)
Cost of goods
Cost of goods
N/A
Cost of goods
£503k (FY, 2017)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$110.8m (FY, 2015)
Gross profit
Gross profit
N/A
Gross profit
£1.9m (FY, 2017)
Gross profit
N/A
Gross profit
N/A
Gross profit
$249m (FY, 2015)
Net income
Net income
N/A
Net income
£319k (FY, 2017)
Net income
($858k) (FY, 2018)
Net income
(£13.7m) (FY, 2017)
Net income
$10.1m (FY, 2015)

Funding

Latest funding round
Latest funding round
$ 500k (over 4 years ago)
Latest funding round
$ 7.5m (over 10 years ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
N/A
Total funding raised
Total funding raised
$ 1.5m
Total funding raised
$ 7.5m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

Cmed
HQ
West Sussex, GB
Employees
290↑ 4% increase

Cmed is a full service, global CRO specialized in the design and delivery of innovative and traditional early phase patient clinical trials.

View company
Hanger
HQ
Austin, US
Employees
4,600

Empowering human potential with innovative technologies, efficient and effective clinical solutions, and outstanding customer service.

View company
Advanced Oncotherapy
HQ
London, GB
Employees
51

Advanced Oncotherapy is a medical technology company providing advanced radiotherapy systems for the treatment of common and rare cancers.

View company
Affymetrix
HQ
Santa Clara, US

Affymetrix develops and provides technologies that enable multiplex and parallel analysis of biological systems at the cell protein, and gene level.

View company